COM. REP. NO. 1409
RE: S.B. No. 1139
Honorable Scott K. Saiki
Speaker, House of Representatives
Thirty-First State Legislature
Regular Session of 2021
State of Hawaii
Your Committee on Consumer Protection & Commerce, to which was referred S.B. No. 1139, S.D. 2, H.D. 1, entitled:
"A BILL FOR AN ACT RELATING TO THE OFFICE OF MEDICAL CANNABIS CONTROL AND REGULATION,"
begs leave to report as follows:
purpose of this measure is to:
(1) Authorize the Department of Health to adopt administrative rules to establish patient registration fees for medical cannabis qualifying patients beginning in fiscal year 2022;
(2) Require the Office of Medical Cannabis Control and Regulation to convene a task force to explore the development of a dual system program of the legalization of cannabis and the impacts of legalization of cannabis on qualifying patients; and
(3) Appropriate monies from the Medical Cannabis Registry and Regulation Special Fund for Office of Medical Cannabis Control and Regulation positions and operations.
Your Committee received testimony in support of this measure from the Department of Health, Akamai Cannabis Clinic, Hawai‘i Cannabis Industry Association, and Big Island Grown Dispensaries. Your Committee received testimony in opposition to this measure from Patients Without Time and one individual.
Committee finds that the financial constraints caused by the COVID-19 pandemic
resulted in the elimination of six critical full-time positions within the
Office of Medical Cannabis Control and Regulation. The Office no longer has administrative staff,
which are fundamental to the effective and efficient operations of the Medical
Cannabis Patient Registry Program and Medical Cannabis Dispensary Program. Administrative and program staff are needed
to meet current statutory requirements and the need for administrative and
programmatic support will only increase as the landscape for medical cannabis
grows and evolves. This measure allows
the Department of Health to establish patient registration fees through
administrative rules, which would give the Office the financial flexibility it
needs to support its ongoing operating costs.
As affirmed by the record of votes of the members of your Committee on Consumer Protection & Commerce that is attached to this report, your Committee is in accord with the intent and purpose of S.B. No. 1139, S.D. 2, H.D. 1, and recommends that it be referred to your Committee on Finance.
Respectfully submitted on behalf of the members of the Committee on Consumer Protection & Commerce,
AARON LING JOHANSON, Chair